Market Tracker

04/23 3:10pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

7.13
Real-Time Quote
 -0.23 / -3.13%
Today’s Change
5.83
Today|||52-Week Range
12.89
-3.52%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close7.36
Today’s open7.33
Day’s range6.90 - 7.42
Volume72,075
Average volume (3 months)201,986
Market cap$337.1M
Dividend yield--
Data as of 2:54pm ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-18.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratio0.2
Price/Sales14.53
Price/Book3.49

Competitors

 Today’s
change
Today’s
% change
DRTXDurata Therapeutics ...-0.23-1.71%
PPHMPeregrine Pharmaceut...-0.01-0.54%
ATNMActinium Pharmaceuti...+0.56+4.43%
DRNADicerna Pharmaceutic...-1.18-6.64%
Data as of 3:09pm ET, 04/23/2014

Financials

Next reporting dateMay 13, 2014
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts